🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/10/2017 | 123,48 | 123,69 | 120,60 | 122,04 | -1,48% | 2,50% | 332.400 |
| 06/10/2017 | 122,87 | 124,89 | 122,39 | 123,87 | -0,06% | 2,03% | 215.700 |
| 05/10/2017 | 122,00 | 124,15 | 120,82 | 123,95 | +1,42% | 2,73% | 216.400 |
| 04/10/2017 | 123,22 | 123,22 | 121,96 | 122,21 | -0,50% | 1,02% | 255.700 |
| 03/10/2017 | 122,98 | 124,00 | 120,37 | 122,82 | +0,21% | 2,95% | 402.400 |
| 02/10/2017 | 117,00 | 123,16 | 116,79 | 122,56 | +4,58% | 5,44% | 519.600 |
| 29/09/2017 | 118,78 | 119,91 | 116,65 | 117,19 | -1,32% | 2,74% | 447.900 |
| 28/09/2017 | 119,08 | 120,64 | 118,08 | 118,76 | -0,59% | 2,15% | 456.400 |
| 27/09/2017 | 119,08 | 120,57 | 117,92 | 119,46 | +0,98% | 2,23% | 308.200 |
| 26/09/2017 | 119,30 | 120,23 | 117,86 | 118,30 | -1,12% | 1,99% | 454.000 |
| 25/09/2017 | 115,14 | 120,12 | 115,04 | 119,64 | +4,40% | 4,41% | 418.100 |
| 22/09/2017 | 115,50 | 115,64 | 114,54 | 114,60 | -0,74% | 0,95% | 372.300 |
| 21/09/2017 | 117,65 | 118,16 | 115,35 | 115,45 | -1,80% | 2,39% | 653.400 |
| 20/09/2017 | 117,43 | 118,52 | 117,07 | 117,57 | +0,03% | 1,23% | 488.300 |
| 19/09/2017 | 120,00 | 121,51 | 117,47 | 117,53 | -1,89% | 3,37% | 470.800 |
| 18/09/2017 | 120,90 | 121,16 | 119,45 | 119,80 | -0,82% | 1,41% | 415.600 |
| 15/09/2017 | 120,85 | 121,73 | 120,46 | 120,79 | -0,18% | 1,05% | 843.000 |
| 14/09/2017 | 123,51 | 123,51 | 120,91 | 121,01 | -1,76% | 2,11% | 349.000 |
| 13/09/2017 | 123,42 | 124,62 | 122,30 | 123,18 | -0,16% | 1,88% | 456.900 |
| 12/09/2017 | 121,04 | 124,04 | 120,17 | 123,38 | +2,18% | 3,20% | 480.500 |
| 11/09/2017 | 121,00 | 121,62 | 119,67 | 120,75 | -0,06% | 1,61% | 697.000 |
| 08/09/2017 | 125,00 | 125,21 | 119,13 | 120,82 | -9,51% | 4,86% | 2.279.200 |
| 07/09/2017 | 134,48 | 134,48 | 132,37 | 133,52 | -1,12% | 1,57% | 915.700 |
| 06/09/2017 | 133,77 | 136,17 | 133,77 | 135,03 | +1,12% | 1,79% | 695.900 |
| 05/09/2017 | 133,48 | 134,08 | 131,91 | 133,53 | +0,13% | 1,63% | 526.300 |
| 01/09/2017 | 130,57 | 134,43 | 129,94 | 133,35 | +1,95% | 3,44% | 508.600 |
| 31/08/2017 | 129,32 | 131,95 | 129,15 | 130,80 | +1,26% | 2,17% | 655.500 |
| 30/08/2017 | 128,09 | 129,93 | 128,09 | 129,17 | +0,61% | 1,44% | 342.600 |
| 29/08/2017 | 129,30 | 129,95 | 128,34 | 128,39 | -0,94% | 1,25% | 363.200 |
| 28/08/2017 | 129,17 | 130,59 | 128,66 | 129,61 | +0,90% | 1,49% | 320.700 |